Suchergebnisse - "Wang, Shengfen"

PubPharm (60)

11

Corrigendum to 'The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives' [Journal of Infection, Volume 80, Issue 4 (2020) Pages 444-453

enthalten in: The Journal of infection | 2022

von Zhou, Y. | Anthony, R. | Wang, S. | +4

ErratumFor: J Infect. 2020 Apr;80(4):444-453. - PMID 31972213

12

Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Liu, D. | Huang, F. | Zhang, G. | +15

13

Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Rifampicin-Resistant Mycobacterium tuberculosis in Hunan, China, Revealed by Whole-Genome Sequencing

enthalten in: Microbiology spectrum | 2022

von He, W. | Tan, Y. | Liu, C. | +11

14

High diversity of clinical Mycobacterium intracellulare in China revealed by whole genome sequencing

enthalten in: Frontiers in public health | 2022

von Song, Z. | Liu, Z. | Ma, A. | +10

15

In Vitro Activity of Pretomanid against Nontuberculous Mycobacteria

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Zheng, H. | Wang, Y. | He, W. | +6

16

Detection of Mycobacterium tuberculosis Rifampicin Resistance Conferred by Borderline rpoB Mutations : Xpert MTB/RIF is Superior to Phenotypic Drug Susceptibility Testing

enthalten in: Infection and drug resistance | 2022

von Xia, H. | Song, Y. | Zheng, Y. | +7

17

Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013

enthalten in: Microbiology spectrum | 2021

von Xia, H. | Zheng, Y. | Liu, D. | +9

18

Assessment The Burden of Recent Transmission of M. Tuberculosis Using WGS Analysis In Golmud City In China

enthalten in: ResearchSquare.com | 2021

von Liu, C. | He, P. | Fan, J. | +6

19

Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China

enthalten in: BMC infectious diseases | 2021

von Zheng, H. | He, W. | Jiao, W. | +7

20

Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China

enthalten in: BMC infectious diseases | 2021

von Zheng, H. | He, W. | Jiao, W. | +7